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Human immunodeficiency virus (HIV-1) infection in the human brain Ieads to characteristic neuropathological 
changes, which may result indirectly from interactions of the envelope glycoprotein gp 120 with neurons and/or glial 
cells. We therefore investigated the binding of recombinant gp120 (rgp120) to human neural cells and its effect on 
int~acellular.s.ignallin~. Herewe pre~ent evidence that rgp120, besides binding to galactocerebroside or galactosyl-sul-
fatlde, spec1f1cally bmds to a protem receptor of a relative molecular mass of approximately 180,000 Da (180 kDa) 
pre~ent. on the CD4-negative glioma cells D-54, but not on Molt4 T lymphocytes. Binding of rgp120 to this receptor 
rap1dly 1nduced a tyrosine-specific protein kinase activity leading to tyrosine phosphorylation of 130- and 115-kDa 
p~oteins. The c~ncentration of intracellular calciumwas not affected by rgp120 in these cells. Our data suggest a novel 
Signal transduc1ng HIV-1 gp120 receptor on CD4-negative glial cells, which may contribute to the neuropathological 
changes observed in HIV-1-infected brains. © 1992Academic Press, lnc. 
INTRODUCTION 
Neuropathological changes in the central nervaus 
system (CNS) of AIDS patients, which Iead to the so-
called AIDSdementia complex (ADC), are of great clini-
cal importance. Manifestations of ADC are progressive 
cognitive, motor, and behavioral dysfunctions that 
have been linked to the persistence of HIV-1 infections 
in the CNS and are mainly found in CD4-positive 
(CD4+) microglial cells and circulating macrophages 
(Budka, 1991; Fauci, 1988; Jordan et al., 1991; Ketzler 
et al., 1990; Liu et al., 1990; Maddon et al., 1986; 
McArthur, 1987; Merrill and Chen, 1991; Price et al., 
1988). However, in the absence of CD4 molecules on 
the cell membrane of the majority of brain cells and in 
the light of the paucity of direct evidence for HIV infec-
tion of neurons and glial cells it has been suggested 
that the HIV-associated degenerative neurological ab-
normalities are the result of indirect mechanisms me-
diated by soluble factors of viral or cellular origin (Bren-
neman et a/., 1988; Dreyer et al., 1990; Giulian et al., 
1990; Kaiser et al., 1990; Pulliam et al., 1991; Wahl et 
al., 1991 ). These factors could be cytotoxic to Subpop-
ulations of brain cells or interfere with neuronal and 
glial cell functions leading to neurodegeneration. 
One such factor, the HIV-1 envelope glycoprotein 
gp120, which is easily shed from infected cells, has 
been studied in the past. lt was found that gp 120 does 
1 To whom reprint requests should be addressed. 
765 
not only bind to the well-known CD4 molecules, but 
also to galactocerebroside (GaiC} and galactosyl-sulfa-
tide, cellular membrane components expressed on the 
surface of oligodendrocytes and other neural cells 
(Harouse et al., 1991; Kuhlmann-Krieg et al., 1988; 
Ranscht et al., 1982). Polyclonal antibodies to GaiC 
can inhibit the entry of HIV-1 in neural celllines, sug-
gesting that the binding of HIV to these membrane 
structures might be of biological significance (Bhat et 
al., 1991; Harouse et al., 1991). However, to mediate 
signals possibly leading to cellular dysfunction, entry of 
viruses into cells is not necessary, but rather the inter-
action of HIV-1 or gp 120 with cell surface receptors 
may be sufficient. lndeed, it was found that treatment 
of neuronal cultures of rodents with gp120 tagether 
with exitatory amino acids resulted in marked in-
creases of intracellularcalcium and ultimately in neuro-
nal cell death (Brenneman et al., 1988; Choi, 1988; 
Dreyer et al., 1990; Kaiser et al., 1990; Lipton et al., 
1991 ). Theseobservations give certainly support to the 
hypothesis that soluble HIV-1 gp120 may interfere not 
only with neuronal, but also with glial cell functions and 
may be associated with the development of ADC. 
To study the effect of HIV-1 gp120 on human brain 
cells, we used the human glioma cellline D-54, which 
does not express CD4 molecules. lnvestigation of 
these cells revealed high-affinity binding of rgp 1 20 to a 
novel trypsin-sensitive receptor. Binding of gp120 to 
these cells was leading to a tyrosine phosphorylation 
of 130 and 11 5 kDa proteins in the absence of any 
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increase of intracellular Ca2+. These data prove that 
binding of a HIV-1 structural protein alone to cell mem-
brane molecules Ieads to signal transduction, which 
could be of pathogenetic significance. 
MATERIALS AND METHODS 
Culture of cells 
The human malignant glioma cell lines D-54 and 
U-373 (Bigner et al., 1981) were cultured in Dulbecco's 
minimal essential medium (DMEM) containing Strepto-
mycin (1 00 ~g/ml}, penicillin (1 00 U/ml), and 5% fetal 
calf serum (FCS) at 37° and 10% C02 • The CD4+ T 
lymphocytic cells Molt4, H9 and C8166, and the CD4-
B lymphocytic cells BJAB were cultured in Roswell Park 
Memorialinstitute (RPMI) 1640 medium containing the 
same additives. 
Polymerase chain reaction 
For PCR, 105 cells were infected with HIV-1 (HTLV-
1118, a kind gift of R. Gallo; m.o.i. = 1 ). After 15 days 
(three passages), DNA was prepared and virus-spe-
cific DNA amplified with the gag-specific primers SK38 
and SK39 and Taq-polymerase (8oehringer-Mann-
heim) as described (Ou et al., 1988). DNA was sepa-
rated on a 1 5% polyacrylamide gel and blotted on ni-
trocellulose. After hybridization with the end-labeled 
41-bp fragment SK19 of HIV-1, filters were exposed to 
X-ray films (DuPont). 
Preparation of RNA and Northern blot 
Total cellular RNA was prepared as described 
(Chirgwin et al., 1979). Poly-A+-RNA was selected on 
oligo-dT-cellulose (Sigma). Eight micrograms of poly-
A+-RNA per lane was separated on 1.5% agarase gels 
containing 6.3% formaldehyde and blotted on Hybond 
N filters (Amersham) by diffusion. As hybridization 
probes the 0.6-kb EcoRI/Sacl fragment of CD4-cDNA 
of plasmid T4-pMV6tklneo (a gift of Dr. D. R. Littman, 
Columbia University, New York) and the 1.3-kb Pstl 
fragment of a plasmid containing the rat glyceralde-
hyde-3-phosphate-dehydrogenase (GAPDH) cDNA 
were labeled with [32P]dCTP with a random-primed la-
beling kit (Boehringer-Mannheim). 
lmmunofluorescent staining and flow cytometry 
To quantify surface molecule expression by flow cy-
tometry, cells were harvested with Ca2+- and Mg2+ -free 
PBS. To partially remove surface proteins, 2 X 105 
cells/tube were incubated with 1 ml 0.1% trypsin in 
P8S for 10 min at room temperature, centrifuged, the 
supernatant aspirated, and washed once with 1 ml me-
dium containing 1 0% FCS and two times with 1 ml 
Ca2+- and Mg2+-free PBS containing 0.2% BSA 
(FACS-buffer). For rgp120-binding studies, cells were 
incubated with 200 ~I 1 JLg/ml rgp120 (strain 1118; MRC 
Directed AIDS Programme) for 1 hr on ice, washed 
three times with FACS-buffer and stained with anti-
gp 120 and FITC-conjugated second antibodies. The 
following monoclonal antibodies (mAbs) were used: 
mause lgG, (Dako) as negative control; anti-CD4 mAb 
OKT4 (Ortho Diagnostics); anti-MHC class I mAb W6/ 
32; anti-GaiC mAb (Boehringer-Mannheim); anti-galac-
tosyl-sulfatide mAb 04 (a gift of M. Schachner, ETH-
ZUrich, Switzerland); anti-gp120 mAb (DuPont); FITC-
conjugated rabbit anti-mouse lg mAb (Dako). 
Labeling of rgp120 with 1251 and binding studies 
Labeling of rgp120 (strain 1118; MRC Directed AIDS 
Programme) was performed by lactoperoxidase with 
single-reaction enzymobead radioiodination reagent 
(Bio-Rad). rgp120 (5 JL9) in 75 ~I 0.2 M phosphate 
buffer, pH 7.2, 25 ~I containing 1.0 mCi Na1251 (Amer-
sham) and 25 ~I containing 1% beta-o-glucose, were 
added to 50 ~I rehydrated enzymobead reagent. The 
reaction mixturewas incubated for 25 min at room tem-
perature, directly applied to a gel filtration column 
(Sephadex-G25), and eluted with PBS into ice-cold 
tubes. Binding studies were performed with fractions 
containing rgp120 labeled to a specific activity of ap-
proximately 1 200 cpm/pmol in 5 ml PBS containing 
0.5% BSA for 2 hr at 4°. Cells were washed three times 
quickly with ice cold PBS 0.5% BSA and cell-bound 
radioactivity and supernatants counted in a gamma-
counter (LK8). 
Chemical crosslinks 
For crosslinking 5 x 1 06 cells were harvested with 
Ca2+- and Mg2+-free PBS and incubated for 2 hr on ice 
with 0.1 ~g [1251]rgp120 in 100 ~1. After washing four 
times with PBS, cells were resuspended in 1 00 ~I P8S. 
The crosslinkers disuccinimidyl-suberate (DSS, stock: 
50 mM in DMSO, Pierce) and bis-(sulfosuccinimidyl}-
suberate (BS3 , stock: 50 mM in PBS, Pierce) were 
added to final concentrations of 0.2 mM, 1 mM, and 5 
mM, and the suspensions incubated 1 hr at room tem-
perature. Cells were lysed by addition of 1 volume Iysis 
buffer (1% Triton X-1 00, 1% Na-deoxycholate, 0.1 o/o 
SOS, 150 mM NaCI, 10 mMTris-HCI, pH 7.4, 0.1 mM 
PMSF), and centrifuged for 10 min at 10,000 g. Super-
natants were separated by polyacrylamide gel electro-
phoresis with 6% sodium dodecylsulfate (SOS-PAGE) 
and dried gels exposed to X-ray films (DuPont) for 7 
days. 
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Fura-2 loading and Ca2+ measurements 
For determination of intracellular Ca2+ 1 07 D-54 cells 
were harvested, washed with buffer A (150 mM NaCI, 
5 mM KCI, 2 mM CaCI, 0.4 mM MgS04 , 25 mM glu-
cose, and 25 mM HEPES, pH 7.3), and resuspended in 
buffer A. Fura-2 AM (1 mM in dimethylsulfoxide) was 
added to a final concentration of 5 p.M. After incubation 
for 1 hr at 36°, the cells were washed twice and resus-
pended in buffer A. Assays were carried out at 32° with 
a modified 4-8202 Aminco-Bowman spectrofluorim-
eter (Silver Spring, MD) fitted with a magnetic stirrer 
and a thermostated cuvette holder. lntracellular fura-2 
fluorescence intensity was measured at two excitation 
wavelengths (340 and 385 nm) and continuously re-
corded at 500 nm. Cells were treated with 0.01-1.0 
p.g/ml rgp120 and for control with 10 U/ml thrombin 
(Sigma). At the end of each individual trace, cells were 
permeabilized with 0.1% Triton X-1 00 to yield the fluo-
rescence signals of high Ca2+. Then 8 mM EGTN50 
mMTris was added to give the fluorescence signals for 
minimal Ca2+ concentration (<1 nm). Ca2+ values were 
calculated according to the equation given in Grynkie-
wicz et al. (1985) using the 340/385 nm ratio of fluores-
cence intensities and the Ca2+ -dye dissociation con-
stant (Kd = 224 nM). 
Detection of phosphotyrosine by Western blot 
Todetermine tyrosine phosphorylation, 5 x 105 cells 
were incubated with rgp120 in 1 ml complete culture 
medium, aspirated and dissolved in 300 p.llysis buffer 
(200 p.l PBS plus 100 p.l 200 mM Tris-HCI, pH 6.8, 5% 
SDS, 15% glycerol, 10% ß-mercapto ethanol, 0.01% 
bromophenol blue), and applied to 8% SOS-PAGE 
(1 00 JLg/lane). A semidry Western blot on nitrocellulose 
filters (Schleicher & SchOll) was performed as de-
scribed (Kyhse-Andersen, 1 984) and the background 
blocked with 1% BSA and 1% gelatine in TNA (1 0 mM 
Tris-HCI, pH 7.2, 150 mM NaCI, 0.01% NaN3) over-
night. Anti-phosphotyrosine monotonal antibody PY20 
(ICN Flow) diluted 1 : 1 000 in blocking buffer was ap-
plied for 2 hr. After washing for 3 x 5 min with TNA and 
5 min with TNA containing 0.05% NP-40, filters were 
incubated with 1251-labeled anti-mause lgG (Amer-
sham) diluted 1 :350 in blocking buffer for 2 hr. Filters 
were washed 6 x 1 0 min with TNA and overnight with 
TNA containing 0.05% NP-40 and exposed to X-ray 
films (DuPont). Sodium orthovanadate (20 JLM) was 
present in all solutions. 
RESULTS 
The human glioma cellline D-54 is CD4-negative 
For our studies on rgp 120-cell interactions we se-
lected D-54 glioma cells, because these cells are 
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F1G. 1. Uptake of HIV-1 by D-54 cells (PCR analysis) and Iack of 
CD4-specific mRNA in D-54 cells (Northern blot). (A) The uptake of 
low amounts of HIV-1 by D-54 cells was measured by polymerase 
chain reaction (PCR). DNA from D-54 cells was amplified with the 
HIV-1 gag-specific primers SK38 and SK39, the amplification prod-
ucts blotted on nitrocellulose and hybridized to a radioactively la-
beled gag-specific probe. The 114 bp HIV-1 gag-specific DNA frag-
ment was detected in D-54 cells 15 days after infection with HIV-1 
(lane 1 ). but not in uninfected D-54 cells (lane 2) and in buffer without 
DNA (lane 3). The HIV-1-infected CD4+ lymphocytes H9 were used 
as positive control (lane 4). Since cellular DNA was amplified, uptake 
and reverse transcription of viral RNA occured in 054 cells. (B) Poly 
A + -RNA from cell lines was blotted on Hybond N filters and hybrid-
ized to a CD4-specific radioactively labeled probe. CD4-specitic 
mRNAwas not detected in D-54 cells (lane 1). ln contrast, the CD4+ 
lymphocytes C8166 expressed CD4 mRNA at 4.5 kb (lane 2). The 
amount of intact RNA on the filter was controled by hybridization 
with a GAPDH-specific probe revealing similar signals for RNA from 
D-54 (lane 3) and C8166 cells (lane 4). The position of 28 S and 18 S 
RNA is indicated as size marker. 
highly responsive to external stimuli like cAMP-analogs 
(Bigner et al., 1981) and might therefore be good can-
didates to investigate signal transduction. We first as-
sessed these cells for susceptibility to HIV-1 and pres-
ence of CD4 molecules. Like the neuronal cell lines 
SK-N-BE and IMR-32 and the glioblastoma line U-373 
(Li et al., 1990; Harouse.et al., 1989}, we found that the 
glioblastoma line 0-54 was nonproductively infected 
with HIV-1. ln the absence of production of infectious 
virus and the development of a cytopathogenic effect 
(CPE), HIV-1-specific DNA could be detected in D-54 
cells by polymerase chain reaction (Fig. 1 A) as weil as 
p24 core antigen, although these cells did not contain 
CD4-specific mRNA or truncated RNAs (Fig. 18). ln ad-
dition, we confirmed by immunofluorescent staining 
and flow cytometry that these cells, in cantrast to the T 
cell line Molt4, did not express CD4 on their surfaces 
(Fig. 2A, 28). Obviously, binding and entry of HIV-1 into 
D-54 cells occured by a CD4-independent mecha-
nism. 
D-54 glioma cells express galactosyl-sulfatide 
GaiC and galactosyl-sulfatide have been found to 
bind HIV-1 gp120 as purified substances and on the 
surface of neural cells (Bhat et al., 1991; Harouse et al., 
1991 ). Therefore, we determined the expression of 
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FIG. 2. Expression of surface molecules and binding of rgp 120 to 
CD4-negative human glioma cells determined by flow cytometry. (A) 
CD4 was not detectable on the surface of D-54 cells: negative con-
trol (signal 1 ). CD4 (signal 2), major histocompatibility complex 
(MHC) class I as positive control (signal 3). (8) As control, CD4 was 
detectable on Molt4 cells: negative control (signal 1 ). CD4 (signal 2), . 
MHC class I (signal 3). (C) D-54 cells did not express GaiC, but 
galactosyl-sulfatide: negative control (signal 1 ), GaiC (signal 2), and 
galactosyl-sulfatide (signal 3). (D) U-373 cells expressed GaiC and 
galactosyl-sulfatide: negative control (signal 1 ), galactosyl-sulfatide 
(signal 2), and GaiC (signal 3). (E) Detection of rgp 120 bound to D-54 
cells by anti-gp120 antibodies: negative control (signal1), rgp120 on 
trypsin-treated D-54 (signal 2), and rgp 120 bound to D-54 cells (sig-
nal3). (F) CD4+ Molt4 cells did bind rgp120: negative control (signal 
1 ), rgp 120 on trypsin treated Molt4 (signal 2), rgp 120 bound to Molt4 
cells (signal 3). 
GaiC and galactosyl-sulfatide on D-54 cells by immuno-
fluorescent staining with monoclonal antibodies and 
flow cytometry. D-54 cells were not stained with anti-
badies to GaiC, but expressed galactosyl-sulfatide on 
their surfaces (Fig. 2C). As control we stained U-373 
cells, which expressed GaiC and galactosyl-sulfatide 
(Fig. 20). We now investigated whether galactosyl-sul-
fatide is the only molecule on D-54 cells capable of 
binding gp120, or if a further class of binding sites 
might be expressed on these cells. 
Binding of rgp120 to cell surfaces 
To roughly estimate the amount of purified CHO cell-
derived recombinant gp120 of HIV-1 (strain 1118) capa-
ble of binding toD-54 cells, we first used immunofluo-
rescent staining methods and analysis by flow cytome-
try. After stringent washing, low, but significant Ievels 
of rgp120 binding to 0-54 cells remained detectable, 
when compared to CD4+ Molt4 cells (Fig. 2E, 2F). ln 
addition, we made the interesting observation that the 
specific binding of rgp120 was decreased after treat-
ment of both celllines with trypsin (Fig. 2E, 2F). Since 
galactosyl-sulfatide is not sensitive to trypsin, these re-
sults suggested the presence of a proteinaus receptor 
for gp 1 20 on the surface of D-54 cells. 
Todetermine the exact binding properties of rgp120 
to D-54 cells, rgp120 was labeled with 1261odine (Fig . 
3A). The affinity constant for the rgp120-D-54 cell in-
teraction was assessed by whole cell binding assays. 
Providing 1261-labeled rgp120 up to a concentration of 
100 nM, we could not reach the Ievei of saturation (Fig. 
38), but the binding of 1251-labeled rgp120 (400 fM/1 06 
cells) was specifically inhibited by 50o/o with approxi-
mately 20 nM unlabeled rgp120 (not shown). Interme-
diate saturation of high-affinity binding sites of rgp1 20 
on D-54 cells was detected already at a free concen-
tration of 300 to 500 fM rgp1 20, whereas at higher 
concentrations low-affinity binding increased. Scat-
chard analysis of these data revealed binding sites with 
a dissociation constant (Kd) of approximately 1 .2 X 
1 o- 10 M for high-affinity and 3.2 X 1o-9 M for low-affin-
ity binding sites (Fig. 3C). The abundance of receptor 
sites on D-54 cells was determined to be approxi-
mately 7 x 1 04/cell for high affinity receptors and more 
than 1 06/cell for lower affinity receptors (average of 
eight experiments). The flow cytometry data suggest 
that at least one of these receptors is trypsin sensitive 
and therefore of proteinaus nature, whereas the other 
is likely to be galactosyl-sulfatide. 
Crosslinking of rgp120 to cell surface molecules 
To investigate the nature of the trypsin-sensitive 
gp120 receptors on D-54 cells, we performed cross-
linking experiments with several chemical crosslinkers. 
Using the crosslinkers disuccinimidyl suberate (DSS) 
and bis(sulfosuccinimidyl) suberate (883), we detected 
one labeled ligand-receptor complex at approximately 
300 kDa with D-54 cells, but not with Molt4 cells (Fig. 
4). The intensity of this 300-kDa band (Fig. 4, lanes 
3-8) was relatively low, as compared to cross-linked 
CD4 molecules on the surface of Molt4 cells (Fig. 4, 
lanes 9-11 ). lncreasing concentrations of cross-linkers 
led to high molecular weight complexes with D-54 and 
Molt4 surface molecules on top of the gel (Fig. 4, lanes 
5, 8, 11 }. The 300-kDa complex is unlikely to consist of 
cross-linked rgp120 molecules itselves, since we did 
not observe bands of dimerized gp120 with a molecu-
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FIG. 3. Labeling of rgp 120 and analysis of binding toD-54 cells. (A) Purified 1251-labeled rgp120 visualized after separation on 10% SDS-PAGE 
by autoradiography. Fractions 2 and 3 from the gel filtration column (lanes 2 and 3) were used for binding studies. (8) To measure binding of 
rgp120 toD-54 cells, 1 x 106 cells in several experiments were incubated with 20 fM to 100 nM 1251-labeled rgp120. The logarithmic binding 
curve of one representative experiment with 1 X 106 D-54 cells is shown. (C) Scatchard analysis of low concentrations of rgp120 binding toD-54 
cells. Binding sites with equilibrium dissociation constants (Kd) of approximately 1.2 x 1 o- 10 M and 3.2 x 1 o-o M were found for high- and 
low-affinity classes of receptors. High-affinity binding corresponded to approximately 7 x 104 binding sites/cell and low-affinity binding to more 
than 106 binding sites/cell. 
lar weight of 240 kDa and trimerized gp 120 with a mo-
lecular weight of 360 kDa and also no bands between 
120 and 240 kDa with D-54 cells. Furthermore, the 
300-kDa complex could not be observed when D-54 
cells were harvested with trypsin or treated with trypsin 
after harvesting (not shown). ln contrast, cross-linking 
on Molt4 cells, which were capable of crosslinking 
much more 1261-labeled rgp120 than D-54 cells, re-
vealed in addition to the 1 80 kDa band also a weak 
1 2 3 4 5 6 7 8 9 10 11 12 
.,. orl 
300kDa .. 
.,. 200kDa 
180kDa .. 
rgp120 .. 
... 97.4 kDa 
FIG. 4. Cross-linking of rgp120 to cell surface proteins of D-54 and 
Molt4 cells. 14C-Iabeled marker proteins had molecular masses of 
200 kDa and 97.4 kDa (lanes 1 and 12). 1261-labeled rgp120 was 
incubated with D-54 cells (lanes 2-8) and with Molt4 cells (lanes 
9-11 ). lncubation of D-54 with 1261-labeled rgp 120 in the absence of 
crosslinker (lane 2) did not Iead to higher molecular weight com-
plexes. lncreasing concentrations (0.2 mM, 1 mM, 5 mM) of the 
cross-linkers disuccinimidyl suberate (DSS) (lanes 3-5 and 9-11) 
and bis(sulfosuccinimidyl) substrate (BS3) (lanes 6-8) led to one li-
gand-receptor complex with an approximate relative molecular 
mass of 300 kDa (lanes 3-8). The crosslink of the CD4 molecule (60 
kDa) on Molt4 cells with rgp 120 was used as positive control giving a 
complex of 180 kDa (lanes 9-11 ). A diffuse band of approximately 
240 kDa was also seen with Molt4 cells, which is likely to consist of 
the dimerization product of rgp 120. Unspecific high molecular 
weight complexes at the top of the gel accumulated with increasing 
concentrations of crosslinkers (lanes 5, 8, 11 ). 
band at 240 kD, probably the dimerization product of 
rgp120. Therefore, the 300-kDa complex observed 
with D-54 cells is likely to consist of 1261-labeled rgp120 
cross-linked to a single 180-kDa molecule. Taken to-
gether, these data indicate that a trypsin-sensitive 
180-kDa cell surface protein might be a high-affinity 
receptor for gp120. 
Determination of intracellular calcium 
concentrations 
Recent reports on the neurotoxicity of gp 120 in cell 
culture suggested that signal transduction through an 
unknown surface molecule may disturb cellular tune-
tians by raising intracellular Ca2+ concentrations ( Bren-
neman et al., 1988; Dreyer et al., 1990; Kaiser et al., 
1990; Pulliam et al., 1991 ). When we measured intra-
cellular Ca2+ concentrations in D-54 cells in response 
to 0.01 to 1 J.Lg/ml rgp120, no increase of Ca2+ Ieveis 
could be detected (Fig. 5A). As control, we measured a 
high response of Ca2+ increase after treatment of cells 
with 10 U/ml thrombin (Fig. 58}, ionomycin and Triton 
X-1 00 (not shown). Thus, intracellular Ca2+ concentra-
tions were not affected by rgp 120 in D-54 cells. 
Activation of tyrosine phosphorylation by rgp 120 
Assessing a different signal transduction pathway, 
namely the activation of cellular tyrosine kinases, we 
observed a rapid induction of tyrosine phosphorylation 
of proteins after interaction of rgp 120 with 0-54 cells 
(Fig. 6). The phosphotyrosine-specific antibody used in 
this Western blot detected a predominant molecular 
species at 130 kDa and a minor band at 115 kDa after 
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FIG. 5. lntracellular calcium concentration in human glioma cells. 
D-54 cells loaded with fura-2 were treated with 1 #'Q/ml rgp120 (A) 
and 1 0 U/ml thrombin (8) as a positive control. The intracellular fluo-
rescence intensity was measured at two excitation wavelengths 
(340 and 385 nm) and continuously recorded at 500 nm with a spec-
trofluorimeter. The computed intracellular Ca2+ concentration (verti-
cal axis) was plotted as a function of time (horizontal axis). No re-
sponse to rgp120 could be detected. 
0.5, 1.0, and 10 min of incubation of cells with 1 JLQ/ml 
rgp120 (Fig. 6, lanes 4-6). Maximal tyrosine phosphor-
ylation was found already 0.5 to 1.0 minutes after 
treatment of D-54 cells with rgp 120. ln contrast, the 
lymphocytic cells Molt4 (Fig. 6, lanes 7-1 0) and BJAB 
(not shown) did not reveal tyrosine phosphorylation in 
response to rgp120. Tyrosine phosphorylation was 
also not observed after treatment of D-54 cells with 
antibodies to galactosyl sulfatide (not shown). lnduc-
tion of tyrosine phosphorylation was completely abol-
ished by pretreatment of the cells with trypsin (Fig. 6, 
lanes 11, 12), indicating that trypsin-sensitive cell 
surface proteins are essential for transmission of the 
signal. 
DISCUSSION 
Our results indicate that a surface molecule of ap-
proximately 180 kDa expressed on the surface of the 
human glioma cells D-54 might be a novel receptor for 
gp120, which transduces either itself, or as a receptor 
complex, a signal leading to tyrosine phosphorylation 
of two proteins with molecular masses of 130 and 115 
kDa. The human glioma cells did not express the main 
HIV-1 receptor CD4 as mRNA or as protein on their 
surfaces.lt has been described that several CD4- cells 
are susceptible to HIV-1, implicating the existence of 
additional HIV-1 receptors on neural cells (Ciapham et 
al., 1989; Harouse et al., 1989, 1991; Kozlowski et al., 
1991; Li et al., 1990; Mizrachi et al., 1991; Schmitt et 
al., 1990). The only known molecular species ex-
pressed on the surface of D-54 cells capable of binding 
gp120 was found to be galactosyl-sulfatide. A similar 
molecule, GaiC, has been described to bind rgp120 
with an affinity of 1.16 x 1 o-10 M (Harouse et al., 1991), 
which is higher than the affinity of rgp 1 20 binding to 
CD4 (2-5 x 1 o-s M; Lasky et al., 1987). We found that 
D-54 cells express two classes of binding sites with 
higher (1.2 x 1 o-10 M) and lower (3.2 x 1o-9 M) affinity 
to rgp120. When compared with the results of Harouse 
et al. ( 1991), our affinity data suggest that the high er 
affinity receptors consist of galactosyl-sulfatide and 
the lower affinity receptors of the trypsin-sensitive cell 
surface proteins. We also determined the binding of 
rgp 120 to trypsin-treated D-54 cells. But the resulting 
values of the binding assays were partially high er than 
of untreated cells and could not be evaluated properly. 
A possible explanation for these results could be that 
galactosyl-sulfatide epitopes are unmasked by the 
treatment with trypsin and led to higher binding values. 
By chemical cross-linking of 1251-labeled rgp 120 to 
cell surface molecules we detected one ligand-recep-
tor complex of approximately 300 kDa. The cross-
linkers 088 and 883 do not link Iipids like galactosyl-
sulfatide to proteins, since reactive amino groups are 
missing. Therefore, the 300-kDa complex cross-linked 
by D88 and 883 is likely to consist of rgp 120 and the 
trypsin-sensitive cell surface component binding 
rgp120. 8ince no smaller complexes of dimerization 
kOa 1 2 3 4 5 6 7 a 9 10 11 12 
200f> 
FIG. 6. Tyrosine phosphorylation induced by rgp120-treated hu-
man glioma cells. 14C-Iabeled marker proteins had the molecular 
masses of 200, 97, 69, and 46 kDa (lane 1 ). The following lanes were 
loaded with the extracts of D-54 and Molt4 cells in culture medium, 
respectively (lanes 2 and 7); D-54 cells incubated with anti-gp 12 0 
antibody (lane 3); D-54 and Molt4 cells incubated with 1 llg/ml 
rgp120 for 0.5, 1, and 10 min, respectively (lanes 4-6 and 8-11); 
D-54 cells preincubated with 0.1% trypsin for 10 min, washed, and 
then incubated with 1 ~'g/ml rgp120 for 0.5 and 1 min (lanes 11 and 
12). lnduced tyrosine phosphorylation of 130 and 115 kDa proteins 
was detected only in the glioblastoma line D-54. 
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products or complexes of degradation products of 
rgp120 were detected with D-54 cells, it is likely that a 
single molecular species of approximately 180 kDa 
was cross-linked to rgp120. The low intensity of the 
cross-linked complex in comparison to the CD4-
rgp120 complex on Molt4 cells is astonishing, since 
the number of CD4 molecules per cell is similar to the 
number of high-affinity receptors and less than the 
number of lower affinity receptors on 0-54 cells. Be-
cause of the low intensity, one could suppose that the 
protein receptor corresponds to the lower abundance, 
higher affinity class of binding sites. However, one rea-
son for the low intensity of the cross-linked complex 
could be that cross-linking of rgp120 with the protein 
receptor with lower affinity to gp120 is competed by 
the higher affinity binding of rgp 1 20 to galactosyl-sulfa-
tide on the surface of 0-54 cells. 
lt was found that antibodies to the membrane Iipid 
GaiC can induce an increase of intracellular Ca2+ con-
centrations in oligodendrocytes, but only after treat-
ment of cells with very high concentrations of antibod-
ies (~4 70 ~g/ml; Dyer and Benjamins, 1 990). We did 
not detect any increase of intracellular Ca2+ in re-
sponse to rgp 120 in D-54 cells. The signal transduc-
tion pathway of the observed tyrosine phosphorylation 
is clearly of a different nature, since antibodies to ga-
lactosyl-sulfatide did not Iead to tyrosine phosphoryla-
tion, and treatment of cell surfaces with trypsin abol-
ished the transduced phosphorylation signal. The tyro-
sine-phosphorylated 130- and 11 5-kDa proteins might 
be subunits of a receptor complex with the cross-
linked 180-kDa rgp120-binding molecule. However, it 
is not possible to clearly judge whether phosphoryla-
tion is inter- or intramolecular based on the rapid ki-
netic of tyrosine phosphorylation in intact cells. Our 
control using CD4 + Molt4 cells did not reveal induction 
of tyrosine phosphorylation in response to rgp 120, 
which is in accordance with the results of Horak et al. 
(1990) forT lymphocytes. Tyrosine phosphorylation of 
proteins with molecular masses in the range of 110 to 
140 kDa has been described to occur after activation 
of many cell surface receptors on brain cells including 
receptors for neurotrophic factors (Soppet et al., 1991; 
Squinto et al., 1991 ), the interleukin-6 receptor (Hibi et 
al., 1990), and receptors of the integrin family (Korn-
berg et a/., 1991 ). lt will be of great interest to identify 
the nature of the receptor complex we found and the 
tyrosine kinase involved. 
Programmed cell death or apoptosis is a physiologi-
cal mechanism involved in normal tissue turnover dur-
ing embryogenesis and adult life, especially in the 
brain, bone marrow and thymus (McConkey et al., 
1990). ln AIDS patients, this mechanism has been 
suggested to be responsible forT helper cell depletion 
(Ameisen and Caprone, 1 991) and could also cause 
cellular dysfunction and atrophy as observed in the 
brain (Fauci, 1988). ln addition, the HIV envelope gly-
coprotein gp 120 has been shown to increase intracel-
lular Ca2+ concentrations tagether with NMDA recep-
tor agonists and to injure rodent neurons in vitro (Bren-
neman et al., 1988; Dreyer et al., 1990; Lipton et al., 
1991 ). These mechanisms and the observed tyrosine 
phosphorylation in response to rgp120 in glial cells 
could provide a combination of signals leading to as-
trocytosis, impairment of myelin, and neurodegenera-
tion as found in brains of AIDS patients. Further experi-
ments are required to investigate the pathogenetic sig-
nificance of this tyrosine kinase signal transduction 
pathway in neuro-AIDS. 
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